WallStreetZenWallStreetZen

NASDAQ: PNTG
Pennant Group Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Pennant Group earnings were $26.8M for the trailing 12 months ending Jun 30, 2025, with 23.1% growth year over year. The latest PNTG earnings report on Jun 30, 2025 announced Q2 2025 earnings of $7.1M, down 8.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PNTG reported annual earnings of $22.6M, with 68.6% growth. The next PNTG earnings date is Nov 10, 2025.

PNTG past earnings growth

How has PNTG's earnings growth performed historically?

Company
23.08%
Industry
11.58%
Market
34.43%
PNTG's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PNTG's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PNTG's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PNTG earnings history

Current Revenue
$798.9M
Current Earnings
$26.8M
Current Profit Margin
3.4%

PNTG Return on Equity

Current Company
9.9%
Current Industry
-213.7%
Current Market
30.7%
PNTG's Return on Equity (9.9%)... subscribe to Premium to read more.
High Return on Equity Performance

PNTG undefined

Current Company
3.8%
Current Industry
7.2%
PNTG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PNTG announces earnings.

PNTG undefined

Current Company
6.44%
Current Industry
15.7%
PNTG has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PNTG vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PNTG$49.09M$26.82M+33.31%$0.80
AMN$38.59M-$165.40MN/A-$4.33
INNV-$4.88M-$30.31MN/A-$0.22
HCSG$35.41M$10.81M-32.74%$0.15
USPH$77.39M$33.28M-0.72%$2.18
View Top Medical Care Facility Stocks

PNTG earnings dates

Next earnings date
Nov 10, 2025

Pennant Group Earnings Reports & History FAQ

What were Pennant Group's earnings last quarter?

On PNTG's earnings call on Invalid Date, Pennant Group (NASDAQ: PNTG) reported Q2 2025 earnings per share (EPS) of $0.21, up 10.53% year over year. Total PNTG earnings for the quarter were $7.09 million. In the same quarter last year, Pennant Group's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Pennant Group stock.

When does Pennant Group report earnings?

The next PNTG earnings call is Invalid Date. Add PNTG to your watchlist to be reminded of Pennant Group's next earnings date.

Is Pennant Group profitable or losing money?

As of the last Pennant Group earnings report, Pennant Group is currently profitable. Pennant Group's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $26.82 million, a 38.78% increase year over year.

What was PNTG's earnings growth in the past year?

As of Pennant Group's earnings date in Invalid Date, Pennant Group's earnings has grown 23.08% year over year. This is 11.5 percentage points higher than the US Medical Care Facilities industry earnings growth rate of 11.58%. PNTG earnings in the past year totalled $26.82 million.

What are Pennant Group's earnings expectations?

The current EPS estimate for Pennant Group's earnings report in Invalid Date is $0.30.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.